UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Funko
FNKO
$328M
| $366K | ﹤0.01% |
38,810
+11,378
| +41% | +$118K |
|
|
NKLA
2352
DELISTED
Nikola Corporation Common Stock
NKLA
| $363K | ﹤0.01% |
9,991
+1,287
| +15% | +$84.4K |
|
|
INDT
2353
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $363K | ﹤0.01% |
+5,469
| New | +$354K |
|
|
NVTA
2354
DELISTED
Invitae Corporation
NVTA
| $363K | ﹤0.01% |
268,529
| – | – |
|
|
HTBK
2355
DELISTED
Heritage Commerce
HTBK
| $362K | ﹤0.01% |
43,451
| – | – |
|
|
WSR
2356
DELISTED
Whitestone REIT
WSR
| $359K | ﹤0.01% |
+38,968
| New | +$377K |
|
2357
XPeng
XPEV
$11.6B
| $358K | ﹤0.01% |
32,205
-21,845
| -40% | -$211K |
|
2358
PetMed Express
PETS
$42.3M
| $357K | ﹤0.01% |
22,010
-2,136
| -9% | -$40.2K |
|
|
ALLK
2359
DELISTED
Allakos
ALLK
| $357K | ﹤0.01% |
80,127
+11,478
| +17% | +$73.4K |
|
2360
Karyopharm Therapeutics
KPTI
$48M
| $356K | ﹤0.01% |
6,109
+584
| +11% | +$28.8K |
|
2361
Ezcorp Inc
EZPW
$1.71B
| $356K | ﹤0.01% |
41,386
-7,964
| -16% | -$70K |
|
|
CIO
2362
DELISTED
City Office REIT
CIO
| $355K | ﹤0.01% |
51,490
+7,195
| +16% | +$60.8K |
|
2363
Mission Produce
AVO
$1.17B
| $355K | ﹤0.01% |
+31,963
| New | +$373K |
|
|
NUVL
2364
DELISTED
Nuvalent
NUVL
| $355K | ﹤0.01% |
13,600
+2,700
| +25% | +$79.9K |
|
2365
Toyota
TM
$225B
| $354K | ﹤0.01% |
+2,500
| New | +$351K |
|
2366
Solid Power
SLDP
$532M
| $354K | ﹤0.01% |
117,626
| – | – |
|
2367
Innoviz Technologies
INVZ
$112M
| $350K | ﹤0.01% |
100,100
+13,400
| +15% | +$59.4K |
|
|
AMK
2368
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $348K | ﹤0.01% |
11,074
| – | – |
|
2369
LivePerson
LPSN
$32.3M
| $345K | ﹤0.01% |
5,212
| – | – |
|
2370
Magnachip Semiconductor
MX
$145M
| $344K | ﹤0.01% |
37,071
| – | – |
|
|
ITOS
2371
DELISTED
iTeos Therapeutics
ITOS
| $342K | ﹤0.01% |
25,161
+4,024
| +19% | +$72.1K |
|
2372
iShares Core S&P 500 ETF
IVV
$904B
| $342K | ﹤0.01% |
+831
| New | +$333K |
|
|
SP
2373
DELISTED
SP Plus Corporation
SP
| $340K | ﹤0.01% |
9,924
-6,840
| -41% | -$242K |
|
2374
Leonardo DRS
DRS
$12B
| $336K | ﹤0.01% |
+25,900
| New | +$335K |
|
|
TRST
2375
Trustco Bank Corp NY
TRST
$938M
| $336K | ﹤0.01% |
10,515
| – | – |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.